Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling
- PMID: 22415859
- DOI: 10.1002/jcb.24128
Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling
Abstract
Repulsive guidance molecules (RGMs) coordinate axon formation and iron homestasis. These molecules are also known as co-receptors of bone morphogenetic proteins (BMPs). However, the role played by RGMs in breast cancer remains unclear. The present study investigated the impact of RGMB on functions of breast cancer cells and corresponding mechanisms. RGMB was knocked down in breast cancer cells by way of an anti-RGMB ribozyme transgene. Knockdown of RGMB resulted in enhanced capacities of proliferation, adhesion, and migration in breast cancer cells. Further investigations demonstrated RGMB knockdown resulted in a reduced expression and activity of Caspase-3, accompanied with better survival in RGMB knockdown cells under serum starvation, which might be induced by its repression on MAPK JNK pathway. Up-regulations of Snai1, Twist, FAK, and Paxillin via enhanced Smad dependent sigaling led to increased capacities of adhesion and migration. Our current data firstly revealed that RGMB may act as a negative regulator in breast cancer through BMP signaling.
Copyright © 2012 Wiley Periodicals, Inc.
Similar articles
-
Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.Int J Oncol. 2012 Feb;40(2):544-50. doi: 10.3892/ijo.2011.1251. Epub 2011 Nov 4. Int J Oncol. 2012. PMID: 22076499
-
Tumour angiogenesis and repulsive guidance molecule b: a role in HGF- and BMP-7-mediated angiogenesis.Int J Oncol. 2014 Sep;45(3):1304-12. doi: 10.3892/ijo.2014.2508. Epub 2014 Jun 20. Int J Oncol. 2014. PMID: 24970050
-
Repulsive guidance molecule b inhibits renal cyst development through the bone morphogenetic protein signaling pathway.Cell Signal. 2016 Dec;28(12):1842-1851. doi: 10.1016/j.cellsig.2016.08.015. Epub 2016 Aug 26. Cell Signal. 2016. PMID: 27575743
-
Repulsive guidance molecules b (RGMb): molecular mechanism, function and role in diseases.Expert Rev Mol Med. 2024 Oct 8;26:e24. doi: 10.1017/erm.2024.24. Expert Rev Mol Med. 2024. PMID: 39375839 Free PMC article. Review.
-
Bone morphogenetic proteins.Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890. Growth Factors. 2004. PMID: 15621726 Review.
Cited by
-
Spatiotemporal expression of repulsive guidance molecules (RGMs) and their receptor neogenin in the mouse brain.PLoS One. 2013;8(2):e55828. doi: 10.1371/journal.pone.0055828. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457482 Free PMC article.
-
Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model.Sci Rep. 2016 Apr 26;6:24968. doi: 10.1038/srep24968. Sci Rep. 2016. PMID: 27113436 Free PMC article.
-
miR-93-5p enhances migration and invasion by targeting RGMB in squamous cell carcinoma of the head and neck.J Cancer. 2020 Apr 6;11(13):3871-3881. doi: 10.7150/jca.43854. eCollection 2020. J Cancer. 2020. PMID: 32328191 Free PMC article.
-
Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting.Cancer Gene Ther. 2022 Oct;29(10):1405-1417. doi: 10.1038/s41417-022-00459-0. Epub 2022 Mar 30. Cancer Gene Ther. 2022. Retraction in: Cancer Gene Ther. 2023 Nov;30(11):1583. doi: 10.1038/s41417-023-00677-0. PMID: 35354949 Free PMC article. Retracted.
-
Exploring the therapeutic promise of targeting Rho kinase in rheumatoid arthritis.Inflammopharmacology. 2021 Dec;29(6):1641-1651. doi: 10.1007/s10787-021-00884-x. Epub 2021 Oct 26. Inflammopharmacology. 2021. PMID: 34704172 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
